Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Purification System

By Drug Discovery Trends Editor | August 26, 2010

gilsonGilson, Inc., an industry leader in purification systems for HPLC, SPE and GPC clean-up, introduces a personal bench top purification system. The Gilson PLC 2020 Personal Purification System provides a complete, compact design with interchangeable pump heads for flow rates of 25 mL/min at 4600 psi, 50 mL/min at 2100 psi, and 100 mL/min at 1200 psi. The system is ideally suited for both high pressure reverse phase and normal phase applications with built in selection of up to 5 separate solvents. The system has electronically actuated manual injections of up to 10 mL volumes and variable dual wavelength UV/VIS detection. All fraction collection control and method creation are controlled from an integrated touchscreen display. The intuitive and simple user interface allows even the most novice user to be purifying compounds in minutes.

A scientist from a leading academic in a drug discovery program had this to say about the new PLC 2020 Personal Purification System, “It’s great to see that a company listens and responds to scientists’ concerns. Gilson’s PLC 2020 is a perfect combination of flexibility, small footprint, cost, and ease-of-use. It’s flexible in the fact that you can use it for everything from low pressure flash runs, up to high pressure/high performance chromatography purifications of various scales. You also have the ability to customize the unit to meet the needs of your application.”

Gilson, Inc.


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50